Document is current

Article History

Received: 16 September 2021

Accepted: 11 March 2022

First Online: 24 March 2022

Declarations

:

: All authors have no formal conflicts of interest to declare. M. A. M. acted as a consultant for Lundbeck and Neurocrine in the past 5 years and also received research funding in the past 5 years from the Medical Research Council, UK, The Wellcome Trust, Lundbeck, Heptares and Takeda. A. V. is supported by the Hellenic Foundation for Research and Innovation (HFRI) under the HFRI PhD Fellowship grant (Fellowship Number: 35). T. L. is in receipt of a PhD studentship funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. O. D., M. A. M. and M. A. H. are supported by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. M. A. H. is also supported by the Medical Research Council, UK.

: The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.